2021-11-16-世界卫生组织-Cervical_cancer_Algeria_2021_country_profile_1页_64kb

Algeria has a cervical cancer profile with moderate burden, characterized by an age-standardized incidence rate of 7.9 per 100,000 women in 2020, 95,100 deaths in 2019, and a mortality-to-incidence ratio of 0.56. Primary prevention is limited, with a HPV vaccination program covering only 46% of target girls aged 9-14 and HPV not included in the national schedule; key risk factors include tobacco use and HIV incidence. Secondary prevention lacks a national screening program, with no recent screening for most women and poor coverage. Treatment resources are constrained, with existing guidelines but few radiotherapy and brachytherapy units, limited staff, and inadequate cancer centers. WHO elimination targets for 2030 are not met, emphasizing gaps in prevention and care.